4//SEC Filing
Foster Jonathan P. 4
Accession 0001437749-25-033682
CIK 0001659617other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 8:24 PM ET
Size
8.2 KB
Accession
0001437749-25-033682
Insider Transaction Report
Form 4
Foster Jonathan P.
EVP & CFO
Transactions
- Exercise/Conversion
Common Stock
2025-11-04+20,625→ 308,212 total - Exercise/Conversion
Common Stock
2025-11-04$0.50/sh−5,023$2,496→ 303,189 total - Exercise/Conversion
Restricted Stock Units
2025-11-04−20,625→ 1,017,695 total→ Common Stock (20,625 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
- [F3]On November 4, 2024, the reporting person was granted 82,500 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
Moleculin Biotech, Inc.
CIK 0001659617
Entity typeother
Related Parties
1- filerCIK 0001545414
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 8:24 PM ET
- Size
- 8.2 KB